HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roles of ROS and PKC-βII in ionizing radiation-induced eNOS activation in human vascular endothelial cells.

Abstract
Vascular endothelial cells can absorb higher radiation doses than any other tissue in the body, and post-radiation impaired endothelial nitric oxide synthase (eNOS) function may be developed as a potential contributor to the pathogenesis of vascular injury. In this study, we investigated early alterations of eNOS signaling in human umbilical venous endothelial cells (HUVECs) exposed to X-ray radiation. We found that ionizing radiation increased eNOS phosphorylation at Ser-1177 and dephosphorylation at Thr-495 in HUVECs in a dose-dependent (≤ 20 Gy) and time-dependent (6-72 h) manner. The total expression levels of eNOS were unchanged by radiation. Although a transient but significant increase in extracellular signal-regulated protein kinase 1/2 (ERK1/2) phosphorylation and a biphasic decline in Akt phosphorylation were observed after irradiation, these inhibitors were without effect on the radiation-induced changes in eNOS phosphorylation. There was an increase in protein kinase C-βII (PKC-βII) expression and the ablation of PKC-βII by small interfering RNA (siRNA) negated the radiation effect on the two eNOS phosphorylation events. Furthermore, when the radiation-induced increase in reactive oxygen species (ROS) generation was prevented by the anti-oxidant N-acetyl-L-cysteine, eNOS Ser-1177 phosphorylation and Thr-495 dephosphorylation in irradiated HUVECs were significantly reduced. However, transfection of PKC-β siRNA did not alter ROS production after irradiation, and NAC failed to block the radiation-induced increase in PKC-βII expression. Taken together, our results suggest that ionizing radiation-induced eNOS activation in human vascular endothelial cells is attributed to both the up-regulation of PKC-βII and the increase in ROS generation which were independent of each other.
AuthorsKimimasa Sakata, Takashi Kondo, Natsumi Mizuno, Miki Shoji, Hironobu Yasui, Tohru Yamamori, Osamu Inanami, Hiroki Yokoo, Naoki Yoshimura, Yuichi Hattori
JournalVascular pharmacology (Vascul Pharmacol) Vol. 70 Pg. 55-65 (Jul 2015) ISSN: 1879-3649 [Electronic] United States
PMID25869503 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Antioxidants
  • Protein Kinase Inhibitors
  • Reactive Oxygen Species
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Proto-Oncogene Proteins c-akt
  • PRKCB protein, human
  • Protein Kinase C beta
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Antioxidants (pharmacology)
  • Cells, Cultured
  • Dose-Response Relationship, Radiation
  • Enzyme Activation
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Human Umbilical Vein Endothelial Cells (drug effects, enzymology, radiation effects)
  • Humans
  • Nitric Oxide Synthase Type III (metabolism)
  • Phosphorylation
  • Protein Kinase C beta (antagonists & inhibitors, genetics, metabolism)
  • Protein Kinase Inhibitors (pharmacology)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA Interference
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction (drug effects)
  • Time Factors
  • Transfection
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: